Arab Pharmaceuticals (ADCI) Revenue
Revenue
EGP 1.33B
Trailing 12 months (TTM)
As of 23 Jul 2026, 19:29 (Cairo time)
Revenue (also called sales or turnover) is the total income a company generates from its core business before any costs or expenses are deducted. For EGX-listed companies it is reported in the annual income statement in Egyptian pounds.
Revenue history
| Fiscal year | Revenue | YoY growth |
|---|---|---|
| 2025 | 1.12B | 42.35% |
| 2024 | 785.52M | 23.95% |
| 2023 | 633.73M | 25.48% |
| 2022 | 505.04M | -5.96% |
| 2021 | 537.05M | 3.12% |
| 2020 | 520.8M | 19.35% |
| 2019 | 436.35M | 13.95% |
| 2018 | 382.93M | 12.95% |
| 2017 | 339.03M | 35.52% |
| 2016 | 250.17M | 11.94% |
| 2015 | 223.49M | 8.43% |
| 2014 | 206.12M | 19.68% |
| 2013 | 172.23M | -4.89% |
| 2012 | 181.08M | — |
| 2010 | 155.34M | 9.05% |
| 2009 | 142.45M | -6.18% |
| 2008 | 151.82M | 3.64% |
| 2007 | 146.49M | -2.3% |
| 2006 | 149.94M | — |
All monetary figures in EGP. Source: Egyptian Exchange via TradingView; annual figures from company disclosures; updated weekly. Prices refresh every 15 minutes during EGX trading hours.